Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERBALIFE LTD.HLF · Entity 4842 | Chief Operating Officer | May 18, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERBALIFE LTD.
Report date May 18, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,062 |
Reported balance
After 2026-05-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-18 · Sale · Disposed 38,377 · Balance 9,062 F1: The reported price is a weighted average price. The Shares were sold in multiple transactions at prices ranging from $12.7550 to $13.1300. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each price within the range set forth above. F2: Includes 3,407 shares acquired under the Issuer's Employee Stock Purchase Plan in 2025 subsequent to the Reporting Person's last Form 4. |
| Common StockSEC Table I · non-derivative | Direct | 26,543 |
Reported balance
After 2026-05-18 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-05-18 · Exercise / conversion · Acquired 17,481 · Balance 26,543 |
| Common StockSEC Table I · non-derivative | Direct | 11,981 |
Reported balance
After 2026-05-18 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-05-18 · Tax withholding · Disposed 14,562 · Balance 11,981 |
| Common StockSEC Table I · non-derivative | Direct | 77,770 |
Reported balance
After 2026-05-18 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-05-18 · Exercise / conversion · Acquired 65,789 · Balance 77,770 |
| Common StockSEC Table I · non-derivative | Direct | 19,706 |
Reported balance
After 2026-05-18 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-05-18 · Tax withholding · Disposed 58,064 · Balance 19,706 |
| Common StockSEC Table I · non-derivative | Direct | 9,706 |
Reported balance
After 2026-05-19 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-05-19 · Sale · Disposed 10,000 · Balance 9,706 F3: The reported price is a weighted average price. The Shares were sold in multiple transactions at prices ranging from $12.2300 to $12.4100. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each price within the range set forth above. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $8.31 · Expires 2035-02-21 | Direct | 34,964 |
Reported balance
After 2026-05-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-05-18 · Exercise / conversion · Disposed 17,481 · Balance 34,964 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $9.58 · Expires 2034-05-03 | Direct | 32,895 |
Reported balance
After 2026-05-18 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-05-18 · Exercise / conversion · Disposed 65,789 · Balance 32,895 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price is a weighted average price. The Shares were sold in multiple transactions at prices ranging from $12.7550 to $13.1300. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each price within the range set forth above.
F2: Includes 3,407 shares acquired under the Issuer's Employee Stock Purchase Plan in 2025 subsequent to the Reporting Person's last Form 4.
F3: The reported price is a weighted average price. The Shares were sold in multiple transactions at prices ranging from $12.2300 to $12.4100. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each price within the range set forth above.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 10,000 | $12.32 | $123,245.00 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · nonDerivative · entry 6 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,706 F3 · price: The reported price is a weighted average price. The Shares were sold in multiple transactions at prices ranging from $12.2300 to $12.4100. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| May 18, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Right · Derivative | 65,789 | $0.00 Strike: $9.58 | $0.00 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · derivative · entry 8 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,895 Underlying: Common Stock · 65,789 shares Expires 2034-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Right · Derivative | 17,481 | $0.00 Strike: $8.31 | $0.00 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · derivative · entry 7 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,964 Underlying: Common Stock · 17,481 shares Expires 2035-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 58,064 | $12.59 | $731,025.76 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · nonDerivative · entry 5 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,706 Read SEC document |
| May 18, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 65,789 | $9.58 | $630,258.62 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · nonDerivative · entry 4 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 14,562 | $12.59 | $183,335.58 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · nonDerivative · entry 3 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,981 Read SEC document |
| May 18, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 17,481 | $8.31 | $145,267.11 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · nonDerivative · entry 2 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 21, 2026 00:50 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 38,377 | $12.93 | $496,310.55 |
DisclosureSEC source: 0001213900-26-059762 · ownership.xml · nonDerivative · entry 1 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,062 F1 · price: The reported price is a weighted average price. The Shares were sold in multiple transactions at prices ranging from $12.7550 to $13.1300. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each price within the range set forth above. F2 · balance_after: Includes 3,407 shares acquired under the Issuer's Employee Stock Purchase Plan in 2025 subsequent to the Reporting Person's last Form 4. Read SEC document |
| May 04, 2026 Filed May 6, 2026 01:39 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 2,877 | $15.82 | $45,514.14 |
DisclosureSEC source: 0001213900-26-052501 · ownership.xml · nonDerivative · entry 2 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,032 F2 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on May 4, 2023. Read SEC document |
| May 03, 2026 Filed May 6, 2026 01:39 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 3,337 | $16.28 | $54,326.36 |
DisclosureSEC source: 0001213900-26-052501 · ownership.xml · nonDerivative · entry 1 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,369 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on May 3, 2024. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 01:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 33,301 | $0.00 Strike: $10.51 | $0.00 |
DisclosureSEC source: 0001213900-26-021908 · ownership.xml · derivative · entry 1 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,301 Underlying: Common Stock · 33,301 shares Expires 2036-02-25 F1 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service through such date. Read SEC document |
| February 25, 2026 Filed Mar 4, 2026 02:25 UTC Amendment | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 33,301 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001213900-26-023332 · ownership.xml · derivative · entry 1 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,301 Underlying: Common Stock · 33,301 shares Expires 2036-02-25 F1 · derivative.exercise_price: This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed. F2 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service through such date. Read SEC document |
| May 04, 2025 Filed May 7, 2025 00:47 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 3,330 | $7.32 | $24,375.60 |
DisclosureSEC source: 0001213900-25-040341 · ownership.xml · nonDerivative · entry 2 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,246 F2 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on May 4, 2023. Read SEC document |
| May 03, 2025 Filed May 7, 2025 00:47 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 2,871 | $7.32 | $21,015.72 |
DisclosureSEC source: 0001213900-25-040341 · ownership.xml · nonDerivative · entry 1 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,576 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on May 3, 2024. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 01:18 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 1,548 | $8.29 | $12,832.92 |
DisclosureSEC source: 0000950170-25-027124 · ownership.xml · nonDerivative · entry 1 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,447 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022. F2 · balance_after: Balance includes shares purchased through the Issuer's Employee Stock Purchase Plan since the Reporting Person's last Form 3 filing on June 10, 2024. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:18 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 52,445 | $0.00 Strike: $8.31 | $0.00 |
DisclosureSEC source: 0000950170-25-027124 · ownership.xml · derivative · entry 2 Hicks Troy · CIK 0002026180 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,445 Underlying: Common Stock · 52,445 shares Expires 2035-02-21 F3 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 21, 2026, February 21, 2027, and February 21, 2028, subject to continued service through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.